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Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, clonal hematopoietic stem cell disorder characterized by the unique triad of 
complement-mediated intravascular hemolytic anemia, 
bone marrow failure, and thrombosis.1 PNH originates 
from a somatic mutation of an X-linked gene, PIGA, 
in a hematopoietic stem cell. The PIGA gene encodes 
a protein subunit of the enzyme complex required for 
the initial step in the biosynthesis of glycosylphos-
phatidylinositol (GPI).2 GPI is a glycolipid moiety, 
which attaches certain proteins to the cell membrane. 
Clinical PNH results from expansion of the PIGA mu-
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BaCkgRounD anD oBjECtIvEs: Paroxysmal nocturnal hemoglobinuria (Pnh), a clonal hematopoietic stem 
cell disorder, manifests when the Pnh clone populates in the hematopoietic compartment. We explored the 
roles of different apoptosis of GPi+ and GPi- (glycosylphosphatidylinositol) cells and CD8+ lymphocytes in a 
selection of Pnh clones. 
patIEnts anD MEthoDs: Granulocytes from Pnh patients and normal controls were subjected to an apop-
tosis assay using annexin V. hematopoietic cell in semisolid media were cultured with or without CD8+ lym-
phocytes. 
REsuLts: in Pnh, CD59+ granulocytes exhibited more apoptosis than their CD59- counterparts, after 0 or 4 
hours in liquid growth culture system (mean [standard error of mean]: 2.1 (0.5) vs 1.2 (0.2), P=.01 at 0 hour 
and 3.4 [0.7] vs 1.8 [0.3], P=.03 at 4 hour, respectively). the presence of mononuclear cells (mnCs) rendered 
a greater difference in apoptosis. the percentages of apoptotic CD59+ granulocytes measured at 4 hours with 
or without mnC fraction were correlated with the sizes of Pnh clones (r=0.633, P=.011; and r=0.648, P=.009; 
respectively). the autologous CD8+ lymphocytes inhibited Cfu-Gm and Bfu-E colony formation in Pnh pa-
tients when compared with normal controls (mean [sEm] of percentages of inhibition: 61.7 (10.4) vs 11.9 (2.0), 
P=.008 for Cfu-Gm and 26.1 (6.9) vs 4.9 (1.0), P=.037 for Bfu-E). 
ConCLusIons: increased apoptosis of GPi+ blood cells is likely to be responsible in selection and expansion 
of Pnh clones. mnCs or possibly CD8+ lymphocytes may play a role in this phenomenon.
tated clone that is deficient in GPI anchored proteins.3 
Lacking the GPI-anchored proteins is the hallmark of 
PNH blood cells and responsible for certain clinical 
features of PNH. For example, intravascular hemolytic 
anemia occurs as a consequence of the deficiency of the 
GPI-anchored membrane inhibitor of reactive lysis 
(CD59) and decay-accelerating factor (DAF).4
 It is unclear how the PNH clone arising from the 
mutated hematopoietic stem cell expands in the bone 
marrow. The PIGA mutation itself does not appear to 
favor growth advantage of the GPI-deficient blood cells. 
In chimeric, PIGA knocked-out mice, the relative size 
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of GPI-deficient clone declined during the prolonged 
follow-up period.5 Moreover, very small populations of 
GPI-deficient blood cells containing PIGA mutations 
have been shown to be present without a tendency to 
expand in normal persons.6 On the other hand, pref-
erential PNH hematopoiesis was observed following 
its engraftment in severe combined immunodeficien-
cy (SCID) mice.7 All the above data suggest that the 
PIGA mutation alone may not be sufficient for clonal 
expansion of PNH-type cells but is likely to confer a 
selective advantage in certain conditions.
 PNH is closely linked to disorders with bone mar-
row failure, especially aplastic anemia.8 PNH frequent-
ly emerges during the clinical course of aplastic anemia 
and more than 30% of patients with PNH had a prec-
edent history of aplastic anemia.9 Moreover, deficient 
hematopoiesis is a feature of PNH as evidenced by 
the frequently observed leukopenia/thrombocytope-
nia, hypocellular marrow, low number of CD34+ and 
progenitor cells CFU-GM and BFU-E.3 In addition, 
PNH-type (GPI-deficient) blood cells have been re-
ported in more than 50% of patients with aplastic ane-
mia.10,11 Persistence and expansion of these PNH-type 
cells to the level of clinical PNH have been observed 
in a proportion of patients.10 Taken together, all of the 
findings suggest that the expansion of a GPI-deficient 
clone is the result of (favorable) selection by a condition 
responsible for the underlying bone marrow failure, ie 
aplastic anemia.12
Based on the underlying immunologic mechanism 
of aplastic anemia, it is likely that escape from immuno-
logic attack by T or natural killer (NK) cells is respon-
sible for the selective survival of PIGA mutant hemato-
poietic stem cells.13 The findings of large granular lym-
phocyte (LGL)-like clonal expansions and abnormal 
T-cell repertoire by size analysis of the complementa-
rity-determining region 3 (CDR3) in the beta variable 
chain (BV) messenger RNA (mRNA) of the T-cell 
receptor (TCR) in PNH patients also favor the role 
T-cell mediated immune processes in the pathogenesis 
of PNH.14,15 According to the above suggestive evi-
dence, PNH is likely to share a common pathogenesis 
with aplastic anemia, which is autoimmune T-cell me-
diated attack of hematopoietic stem cells, with a spar-
ing and subsequent expansion of GPI- cells. Recently, 
increased susceptibility to apoptosis of GPI+ cells has 
been shown to be responsible to preferential growth of 
GPI- cells in PNH patients.16 Since apoptosis of targets 
may be a consequence of T-cell mediated cytotoxicity,17 
it is possible that increased apoptosis in GPI+ hemato-
poietic stem cells in patients with PNH is the result of 
T-cell mediated autoimmune selection of PNH hema-
topoiesis. Our study was, therefore, designed to explore 
the roles of different apoptosis and cytotoxic (CD8+) 
lymphocytes in the selection of PNH clones in patients 
with PNH.
patIEnts anD MEthoDs
Patients and normal controls
PNH patients followed at the Division of Hematology, 
Department of Medicine, Faculty of Medicine, Siriraj 
Hospital, Mahidol University, voluntarily participated 
in this study. The diagnosis of PNH was confirmed by 
positive Ham test and/or the presence of CD59- blood 
cells (erythrocytes and/or granulocytes) by flow cyto-
metric analyses. Thirty-three healthy volunteers were 
also included in this study as normal controls. This 
study was approved by the ethical committee (IRB) 
of the Faculty of Medicine, Siriraj Hospital, Mahidol 
University.
Blood samples and cell separation
Twenty mL of heparinized blood obtained from the 
patients and healthy volunteers after obtaining in-
formed consent, was divided into two parts. A portion 
of 10 mL of the heparinized blood was separated for 
leukocyte fraction (from erythrocytes) by 6% dex-
tran sedimentation. The leukocyte fraction was then 
subjected to centrifugation gradient through Ficoll-
Hypaque (Pharmacia, Uppsala, Sweden) to separate 
mononuclear cells (MNCs) from polymorphonuclear 
cells (PMNs).18 After washing with phosphate buffered 
saline (PBS), and being suspended in Rosewell Park 
Memorial Institute (RPMI)-1640 medium (Gibco, 
Grand Island, NY, USA) supplemented with 1% 
L-glutamine, 10% fetal calf serum (FCS), 50 µg/mL 
streptomycin, and 50 IU/mL penicillin, the leukocyte 
suspension was used for apoptosis analyses.
 The second part of the 10 mL of heparinized blood 
was separated for MNC fraction by centrifugation gra-
dient through Ficoll-Hypaque (Pharmacia, Uppsala, 
Sweden). The separated MNCs were washed twice and 
suspended with PBS/EDTA buffer at a concentration 
of 107/100 µL for the uses of hematopoietic progenitor 
cell co-culture study and also for purification of CD8+ 
and CD8- cells.
Apoptosis and flow cytometry analysis
Apoptosis analysis was carried out following a num-
ber of pilot experiments to find out the optimal con-
dition for the study. Briefly, 1×106 polymorphonuclear 
(PMN) leukocytes were cultured alone as control and 
co-cultured with 1×106 MNCs in 1 mL of RPMI-1640 
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supplemented with 1% L-glutamine, 10% FCS, 50 µg/
mL streptomycin, and 50 IU/mL penicillin. After 0- 
and 4-hour cultures or co-cultures, 0.5 mL of cell sus-
pension was incubated with 50 µl of anti-CD59 biotin 
conjugated, 7 µl of anti-CD45 per-CP, 2 µL of annexin-
V FITC, and 100 µL of binding buffer and incubated 
at 2°C to 8°C for 15 minutes. Annexin-V binding in 
the CD59+ and CD59- cell populations were deter-
mined by three-color analysis of flow cytometry. The 
gated granulocytes, based on side- and forward-scatter 
properties and expression of CD45, were analyzed for 
annexin-V positivity as shown in dot plots separated 
in four quadrants (Figure 1). Apoptotic CD59+ and 
CD59- granulocytes are shown in upper right (UR) 
and lower right (LR) quadrant, while non-apoptotic 
CD59+ and CD59- granulocytes are shown in upper 
left (UL) and lower left (LL) quadrant, respectively. 
The proportion of apoptotic CD59+ or CD59- granu-
locytes was expressed in percentage as the number of 
apoptotic granulocytes (UR or LR) divided by the total 
number of each granulocyte population (UR+UL or 
LR+LL).
Purification of CD8- and CD8+ cells
Purification of CD8- cells was done by indirect immune-
magnetic activated cell sorter. Briefly, 107 of MNCs in 
100 µL PBS/EDTA were incubated with 70 µl of anti-
CD8 PE antibody for 15 minutes at room temperature 
(RT). The stained cells were washed with 50 mL of the 
buffer with centrifugation at 2000 rpm for 5 minutes. 
The cell pellet was then suspended in 80 µL of buffer 
and incubated with 20 µL of goat anti-mouse-IgG mi-
crobeads for 15 minutes at 2°C to 8°C. The suspension 
was subsequently washed with the same amount of the 
buffer and centrifugation. After complete discard of su-
pernatant, the cell pellet was re-suspended in 0.5 mL of 
buffer. The final cell suspension was applied onto the 
prepared LS column (Miltenyi Biotec, Earhart Avenue 
Auburn, CA, USA), for magnetic separation of CD8+ 
and CD8- fractions according to the manufacturer’s 
guideline. 
Hematopoietic progenitor cell assay
After purification by indirect immune-magnetic ac-
tivated cell sorter, 4×105 of CD8- cells and 1×105 of 
CD8+ cells were co-cultured in methocult (Stem Cell 
Technologies, Vancouver, Canada), containing 1% 
methylcellulose in IMDM, 30% FBS, 1% BSA, 10-4 
M 2-mercaptoethanol, 2 mM L-glutamine, 50 ng/
mL stem cell factor, 10 ng/mL GM-CSF, 10 ng/mL 
interleukin 3, and 3 U/mL erythropoietin, and plated 
onto 35 mm culture dishes in duplication. As a control, 
4×105 cells from CD8- cell fraction were also cultured 
alone. Each culture was incubated for 14 days at 37°C 
in 5% CO2 condition. Colonies consisting of at least 50 
cells were enumerated and characterized, according to 
their morphology, by an inverted microscope.
Statistical analysis
Differences between groups and parameters were eval-
uated by the Mann-Whitney test and the Wilcoxon 
signed-rank test. The Pearson correlation was used to 
determine the relationship between the proportions of 
the apoptotic CD59 negative and positive granulocytes 
and hematological parameters. Statistical significance 
was considered when the P value was <.05.
REsuLts
Patient characteristics and the sizes of PNH clones 
Among the 15 patients studied, there were 6 females 
and 9 males who ranged in age from 28 to 68 years with 
a median age of 39 years (Table 1). Ten (67%) of the 
patients were in the category of classic or hemolytic 
PNH while the other 5 (33%) had cytopenias other 
than anemia and were classified as PNH/aplastic ane-
mia (PNH/AA). Six patients (40%) had a pre-existing 
history of aplastic anemia. Nearly all patients had mild 
disease and their base-lined hemoglobin concentra-
tions; defined as the average hemoglobin concentra-
tions of the previous three visits before studies, were 
5-13 g/dL (mean and median were equal at 10.2 g/dL). 
All except two patients were transfusion independent. 
Sizes of PNH clones as estimated by the percentages 
of CD59- granulocytes were between 25.9% to 98.3%, 
the mean (standard error of mean) was 68.1 (6.6) and 
median 75.6.
Different apoptosis between CD59+ or CD59- granulo-
cytes
The percentages of apoptosis of granulocytes (PMNs) 
in liquid growth culture without and with 1:1 mononu-
clear cell fraction are shown in Table 2. After 0 hour or 
4 hours in liquid growth culture system, CD59+ granu-
locytes from PNH patients exhibited more apoptosis 
than the CD59- counterparts (mean [standard error of 
mean]: 2.12 [0.47] median 1.59, vs 1.20 [0.20], median 
0.96, P=.01 at 0 hour and 3.35 [0.67], median 2.95 vs 
1.82 [0.26], median 1.62, P=.03 at 4 hours, respective-
ly). Co-culture of granulocytes with mononuclear cells 
for 4 hours seemed to render more difference in apop-
tosis between the CD59+ granulocytes (mean [SEM]: 
3.35 [0.66] median 2.25) and the CD59- cells (mean 
[SEM]: 1.67 [0.29], median 1.60); P=.005.
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 When compared with normal controls, CD59+ 
granulocytes from PNH patients were more apoptotic 
than the CD59+ granulocytes from normal controls 
in culture without MNCs at 0-hour culture (mean 
[SEM]: 2.12 [0.47], median 1.59 for PNH patients vs 
0.74 [0.11], median 0.47 for normal controls; P=.002). 
Similar findings were also observed in co-culture with 
MNCs at 0-hour culture (mean [SEM]: 1.78 [0.33], 
median 1.28 for PNH patients vs 0.68 [0.07], me-
dian 0.60 for normal controls; P=.002) or at 4-hour 
culture in the presence of MNCs (mean [SEM]: 3.35 
[0.66], median 2.25 for PNH patients vs mean [SEM]: 
2.10 [0.37], median 1.36 for normal controls; P=.02) 
(Figure 2). However, the percentages of apoptotic 
Table 1. demographic, clinical, hematologic data and sizes of pnH clones (% Cd59- granulocytes).
UPN Sex Age (yrs) Disease category Hb (g/dL) WBC (×109/L) Platelet(×109/L)
% CD59-
granulocytes
1 F 28 pnH/aa 5.0 4.8 92 98.30
2 M 38 Classic pnH 7.5 6.08 198 79.65
3 M 50 Classic pnH 8.4 5.73 49 27.07
4 F 55 Classic pnH 12.4 5.0 355 91.40
5 F 38 Classic pnH 11.0 6.67 142 75.57
6 M 68 pnH/aa 9.4 3.66 32 25.87
7 F 31 pnH/aa 12.1 3.14 71 36.74
8 F 60 Classic pnH 10.2 7.41 178 94.7
9 M 47 Classic pnH 11.1 11.64 172 65.16
10 M 39 Classic pnH 9.2 4.18 170 34.40
11 M 35 pnH/aa 10.6 2.69 43 66.40
12 F 45 Classic pnH 11.4 6.06 100 75.84
13 M 39 Classic pnH 13.1 4.22 91 97.0
14 M 34 pnH/aa 11.0 4.40 41 84.73
15 M 32 Classic pnH 10.0 6.04 230 69.06
Upn=unique patient number
Table 2. percentages of apoptosis of Cd59+ and Cd59- granulocytes.
% apoptosis of granulocytes in culture
Without mononuclear cells With mononuclear cells
Time of culture 0 hour 4 hours 0 hour 4 hours
Cell population Cd59+ Cd59- Cd59+ Cd59- Cd59+ Cd59- Cd59+ Cd59-
Normal controls 0.74 (0.11)d nd 3.24 (0.52) nd 0.68 (0.07)e nd 2.10 (0.37)f nd
PNH patients 2.12 (0.47)a,d 1.20 (0.20)a 3.35 (0.67)b 1.82 (0.26)b 1.78 (0.33)e 1.31 (0.27) 3.35 (0.66)c,f 1.67 (0.29)c
aP=.01; bP=.03; cP=.005; dP=.002; eP=.002; fP=.02. Values are mean (standard error of mean).
CD59+ granulocytes from normal controls and the 
patients in culture without MNCs were not different 
(mean [SEM]: 3.35  [0.67], median 2.95 for PNH pa-
tients vs 3.24 [0.52], median 2.44 for normal controls; 
P=.40).
The relationship between the percentages of apoptotic 
CD59+ granulocytes and hematologic parameters and 
sizes of PNH clones
The percentages of apoptotic CD59+ granulocytes 
measured at 4 hours without or with MNC fraction 
were correlated with the sizes of PNH clones as repre-
sented by percentages of CD59- granulocytes (r=0.648, 
P=.009 and r=0.633, P=.011; respectively). They also 
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had negative correlations with the base-lined Hb con-
centration of patients (r=-0.722, P=.002 and r=-0.649, 
P=.009; respectively) (Figure 3). While the percent-
ages of apoptotic CD59+ granulocytes measured at 0 
hour did not correlate with hemoglobin concentration, 
they had some correlation with the sizes of PNH clones 
(r=0.517, P=.049). There was no significant relation-
ship between apoptotic CD59+ granulocytes and other 
hematologic parameters, such as white blood cell count 
or platelet count.
Hematopoietic progenitor growth with or without CD8+ 
lymphocytes
Hematopoietic progenitor growth with or without 
CD8+ lymphocytes were studied in 5 patients with 
PNH and 5 normal controls. In accordance with our 
previous study,3 the numbers of BFU-E and CFU-GM 
in patients with PNH were significantly lower than 
those from normal controls. When compared between 
cultures performed with or without the CD8+ fraction, 
the numbers of BFU-E and CFU-GM in normal con-
trols were not different (mean [SEM]: 220.30 [20.85] 
vs 234.60 [23.26], P=.18 for BFU-E and 15.70 [2.65] 
vs 16.90 [3.69], P=.59 for CFU-GM).
In contrast, the numbers of CFU-GM of PNH pa-
tients were lower in culture with the presence of CD8+ 
fraction than those in culture without CD8+ cells. 
(mean [SEM]: 1.50 [0.71] vs 3.10 [1.16], P=.04 for 
CFU-GM and 28.80 [8.96] vs 30.20 [10.06], P=.67 
for BFU-E). The percentages of inhibition by CD8+ 
lymphocytes, as represented by the differences of the 
numbers of colonies in cultures with and without 
CD8+ cells divided by the numbers of colonies in cul-
tures without CD8+ cells, were significantly higher for 
both CFU-GM and BFU-E in PNH patients as com-
pared to normal controls (mean [SEM]: 61.69 [10.37] 
vs 11.93 [1.96], P=.008 for CFU-GM and 26.08 [6.9] 
vs 4.90 [1.00], P=.037 for BFU-E) (Figure 4).
DIsCussIon
It remains unclear how a GPI-deficient clone arising 
from a mutated hematopoietic stem cell expands in 
PNH. Ample evidence suggest that the selective ex-
pansion of PNH clones is not simply attributable to 
the PIGA mutations alone.19,20 The strong association 
of PNH with aplastic anemia, in which immune (T 
cell)-mediated marrow destruction has been inferred 
as the underlying pathophysiology, suggests an immune 
mechanism of selection. However, so far there has been 
no in vitro experiment which directly demonstrates 
both the cellular and molecular mechanism of immune 
escape of the PNH clone.21 Recently, there have been 
Figure 1. Flow cytometric analysis of apoptotic granulocytes as shown by dot-plot 
scattergram. granulocytes were gated with forward and side scatters (FSC/SSC) 
(r1).  Only Cd45 (leukocyte antigen) positive granulocytes (r2) were further analyzed 
to examine expression of gpi-anchored Cd59 and annexin-V binding. Lower dot-plot 
scattergram shows granulocytes with normal phenotype (Cd59+ granulocytes) in upper 
left (UL) and upper right (Ur) quadrants.  granulocytes with pnH phenotype (Cd59- 
granulocytes) are shown in lower left (LL) and lower right (Lr) quadrants.  granulocytes 
with annexin-V positive indicating cell apoptosis are shown in Ur and Lr quadrants; 
non-apoptotic granulocytes with annexin-V negative are shown in UL and LL quadrants.
Figure 2. Comparison 
of percentages of 
apoptotic Cd59+ 
granulocytes from 
normal controls and 
patients with pnH. 
More apoptotic 
Cd59+ granulocytes 
were observed in 
the patients than 
in controls in both 
cultures with MnCs 
at 0 hour (A) (mean 
[SeM]: 1.78 [0.33], 
median 1.28 for 
pnH patients vs 
0.68 [0.07], median 
0.60 for normal 
controls; P=.002) 
and at 4 hours (B) 
(mean [SeM]: 3.35 
[0.66], median 2.25 
for pnH patients vs 
mean [SeM]: 2.10 
[0.37], median 1.36 
for normal controls; 
P=.02). The results 
are expressed in 
box plot as medians, 
25th-75th, and 10th-
90th percentiles.
original research reportpnH CLOneS
Hematol Oncol Stem Cell Ther 5(3)     Third Quarter 2012 hemoncstem.edmgr.com 143
Figure 3. Scattergram to demonstrate the correlation between % apoptosis of Cd59+ 
granulocytes and % Cd59- (pnH) granulocytes in cultures at 4 hours without MnCs 
(A) (r=0.648, P=.009) and with MnCs (B) (r=0.633, P=.011). While, the percentages of 
apoptotic Cd59+ granulocytes had negative correlations with Hb concentrations in 
cultures at 4 hours without MnCs (C) (r=-0.722, P =.002) and with MnCs (D) (r=0.649, 
P=.009).
studies suggesting that difference in apoptosis of GPI+ 
and GPI- cells may be responsible for the clonal expan-
sion of GPI-negative (PNH) clone.16,22
 In our study, we explored both the effect of immune 
selection via CD8 cells, which represented cytotoxic 
lymphocytes and also the role of different apoptosis in 
PNH clonal evolution. Using peripheral blood granu-
locytes as representative cells, we found that the GPI+ 
cells (CD59+ granulocytes) from PNH patients ex-
hibited more apoptosis than their GPI- counterparts 
(Table 2). In the presence of mononuclear cells (for 4 
hours), the difference of apoptotic tendency between 
the two cell populations seemed to be more. Moreover, 
the GPI+ granulocytes from PNH patients were more 
apoptotic than those from normal controls, including 
in the cultures with mononuclear cells (Figure 2). Our 
findings as well as those from other studies suggest that 
different apoptosis between GPI+ and GPI- blood cells 
plays a role in PNH clonal evolution.16,22 Our findings 
of the relationships between the magnitude of apop-
totic CD59- granulocytes with the sizes of PNH clones 
and the base-lined hemoglobin concentrations (Figure 
3) also supported the significance of the difference in 
apoptosis of GPI+ and GPI- cells in the pathogenesis of 
PNH. More apoptosis of the GPI+ cells leads to PNH 
clonal dominance by leaving more survival of the GPI- 
(PNH) cells. The sizes of PNH clones also determine 
severity of the disease or anemia as suggested by our pre-
vious study,23 which may explain the negative correlation 
between the percentages of apoptotic CD59- granulo-
cytes and the base-lined hemoglobin concentrations of 
the patients. 
 It is debatable whether the difference in apoptotic 
rates of GPI+ and GPI- cells is due to the resistance of 
GPI- blood cells to apoptosis24 or because the GPI+ 
cells are susceptible to apoptosis.25 There have been 
controversial data suggesting that a mutation of PIGA 
confers resistance to apoptosis to GPI deficient blood 
cells leading to expansion of the PNH clone.24-27 Our 
findings of higher apoptosis rates of GPI+ cells from 
PNH patients than those from normal controls, other 
than the GPI- counterparts, suggests that the non-mu-
tated PIGA cells are predisposed to apoptosis leaving 
the GPI-deficient blood cells to be selected and subse-
quently expand. Our data provide additional evidences 
supporting the concept that PNH clonal evolution oc-
curs as a result of increased susceptibility of GPI+ cells 
to apoptosis, as suggested by a study using DNA mi-
croarray.28 It is likely that this phenomenon occurs as a 
result of extrinsic influence, constituted as the selective 
immunologic attack of GPI+ blood cells by effectors 
such as cytotoxic T or NK lymphocytes leading to in-
Figure 4. effect of Cd8+ lymphocytes on CFU-gM and bFU-e formations. The results are 
shown by box-plots of percentages of inhibition. The percentages of inhibition by Cd8+ 
lymphocytes were significantly higher in pnH patients than normal controls for both 
CFU-gM (A) (mean [SeM]: 61.69 [10.37] vs 11.93 [1.96], P=.008) and bFU-e (B) (26.08 [6.9] 
vs 4.90 [1.00], P=.037).
duction of apoptosis of the target cells.28-30 The finding 
of a tendency of increased apoptosis in the presence of 
MNCs which are a source of effector cells also favors 
this suggestion. Although our findings do not explain 
why the unmutated GPI+ cells are selectively destroyed, 
it is likely that the GPI-anchored proteins or the GPI 
itself are the prime targets of the immune recognition by 
the effector cells.
 With hematopoietic progenitor cell assay, the num-
bers of BFU-E and CFU-GM in patients with PNH 
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were significantly lower than those from normal con-
trols, indicating a condition of deficient hematopoiesis 
in patients with PNH.3 In the patients, but not in the 
normal controls, the numbers of CFU-GM were signif-
icantly lower in cultures with autologous CD8+ lym-
phocytes than in those without these cells. Moreover, 
the effects (percentages) of inhibition of progenitor cell 
growth (both CFU-GM and BFU-E) by autologous 
CD8+ lymphocytes were more in the patients than 
in normal controls. Our findings are consistent with 
other studies of different approaches and suggest that 
cytotoxic T lymphocytes (CTLs) are responsible for the 
condition of deficient hematopoiesis or bone marrow 
failure and also play an important role in the immune 
selection of PNH clones in patients with PNH.14,31,32 
Our findings do not exclude the role of NK cells in 
immune selection of PNH blood cells as suggested by 
Hanaoka et al30 since CD8+ may also be expressed on 
NK cells.33 However, a study has shown that NK cells 
may be less efficient in targeting GPI-deficient cells.34 
 Under the process of immune selection, the CTLs 
are supposed to target and inhibit growth of the GPI+ 
hematopoietic stem/progenitor cells through effec-
tor mechanisms which may involve direct granzyme/
perforin cytotoxicity, CTL-mediated secretion of in-
hibitory cytokines such as IFN-a and TNF-a.35 All of 
these mechanisms have been shown to induce apoptosis 
of target cells.17 In spite of using different approaches 
and targets, our findings of inhibition of progenitor cell 
growth by CTLs and increased apoptosis of CD59+ 
granulocytes convince the role of CTLs in preferential 
growth of GPI- hematopoietic stem cells through cy-
totoxicity-induced apoptosis. Elevated Fas receptor ex-
pression in GPI+ stem cells, which was found by some 
investigators,25 may render more CTL-induced apop-
tosis of these cells and enhance more growth advantage 
of GPI- stem cells leading to PNH clonal dominance.
 In summary, we have shown that more apoptosis of 
the GPI+ blood cells than their GPI- counterparts is 
responsible for the selection of PNH clones with sub-
sequent clonal expansion in PNH. MNCs, especially 
the auto-reactive CD8+ lymphocytes, may play a role 
in this phenomenon by selectively suppression of non-
PNH hematopoiesis, through cytotoxicity-induced 
apoptosis.
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